Stock OGN ORGANON & CO.
Add to a list
To use this feature you must be a member
Log inSign up

All News Organon & Co.

Equities

OGN

US68622V1061

Real-time Estimate Cboe BZX
Other stock markets
 03:32:38 2024-06-07 pm EDT 		5-day change 1st Jan Change
20.78 USD +0.51% Intraday chart for Organon & Co. -2.60% +44.07%
May. 24 Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation MT
May. 24 Shanghai Henlius Biotech, Inc. and Organon Announces That the European Medicines Agency Has Validated the Marketing Authorization Applications for Hlx14 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Organon, Henlius' Denosumab Biosimilar HLX14 Gets European Validation
MT
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
BU
Shanghai Henlius Biotech, Inc. and Organon Announces That the European Medicines Agency Has Validated the Marketing Authorization Applications for Hlx14
CI
Organon & Co and Organon Foreign Debt Co-Issuer B.V Closes Their Previously Announces Private Offering of $500 Million of 6.750% Senior Secured Notes Due 2034 and $500 Million of 7.875% Senior Unsecured Notes Due 2034
CI
Organon Reports Pricing of $1 Billion Senior Notes Offering
MT
Organon Announces Pricing of $1.0 Billion Senior Notes Offering
BU
Organon & Co. and Organon Foreign Debt Co-Issuer B.V. Announces Pricing of $1.0 Billion Senior Notes Offering
CI
Organon Plans Offerings of Secured, Unsecured Senior Notes Totaling $1 Billion
MT
Organon Announces Proposed $1.0 Billion Senior Notes Offering
BU
Organon & Co. and Organon Foreign Debt Co-Issuer BV Announces Proposed $1.0 Billion Senior Notes Offering
CI
Organon : Q1 2024 Transcript
PU
Organon's Q1 Adjusted Earnings, Revenue Rise; 2024 Revenue Guidance, Quarterly Dividend Maintained
MT
Organon : Q1 2024 Earnings Presentation
PU
Organon : 2024 Annual Meeting of Shareholders
PU
Transcript : Organon & Co., Q1 2024 Earnings Call, May 02, 2024
Earnings Flash (OGN) ORGANON & CO. Reports Q1 Revenue $1.62B, vs. Street Est of $1.56B
MT
Organon: Q1 Earnings Snapshot
AQ
Earnings Flash (OGN) ORGANON & CO. Reports Q1 EPS $1.22, vs. Street Est of $0.93
MT
Organon Reports Results for the First Quarter Ended March 31, 2024
BU
Organon & Co. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OGN Stock
  4. News Organon & Co.